Q BioMed Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.66 |
Market Cap |
$20.22 M |
Shares Outstanding |
14.65 M |
Public Float |
9.21 M |
Address |
366 Madison Avenue New York New York 10017 United States |
Employees | - |
Website | http://www.qbiomed.com |
Updated | 07/08/2019 |
Q BioMed, Inc. operates as a biomedical acceleration and development company. It is focused on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. The company products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. |